Supplementary Table 3 from Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine
Authors:
- Evan C. ChenECEvan C. Chen
- Yiwen LiuYLYiwen Liu
- Hayden L. BellHBHayden L. Bell
- Jeremy RyanJRJeremy Ryan
- Jason WuJWJason Wu
- Emma-Jayne MinihaneEMEmma-Jayne Minihane
- Marlise R. LuskinMLMarlise R. Luskin
- Eric S. WinerEWEric S. Winer
- Rahul VedulaRVRahul Vedula
- Virginia VolpeVVVirginia Volpe
- Maximilian StahlMSMaximilian Stahl
- Daniel RobertsDRDaniel Roberts
Open Access
- 14 August 2026
- other
- Published by American Association for Cancer Research (AACR)